RituximabCOVID-19 pneumonia

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2017卷 / 1期

关键词：

D O I：

10.1007/s40278-024-63415-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：439 / 439

相关论文

共 50 条

[41] Azathioprine/leflunomide/rituximabCOVID-19: 3 case reports
Reactions Weekly, 2023, 1971 (1) : 52 - 52
[42] Ocrelizumab/rituximabCOVID-19 infection: 2 case reports
Reactions Weekly, 2021, 1870 (1) : 258 - 258
[43] Infliximab/rituximabCOVID-19 infection: 10 case reports
Reactions Weekly, 2022, 1895 (1) : 221 - 221
[44] Azathioprine/rituximabCOVID-19 reinfection: 2 case reports
Reactions Weekly, 2025, 2053 (1) : 66 - 66
[45] Immunosuppressants/rituximabCOVID-19 infection: 23 case reports
Reactions Weekly, 2022, 1913 (1) : 254 - 254
[46] Fingolimod/rituximabCOVID-19 and reduced humoral immunity: 3 case reports
Reactions Weekly, 2023, 1968 (1) : 143 - 143
[47] RituximabCovid-19 infection following exposure during pregnancy: case report
Reactions Weekly, 2023, 1946 (1) : 490 - 490
[48] Remdesivir/rituximabCOVID-19 infection and COVID-19 infection rebound: case report
Reactions Weekly, 2022, 1927 (1) : 461 - 461
[49] Bendamustine/obinutuzumab/rituximabCOVID-19 infection and prolonged COVID-19 virus positivity: case report
Reactions Weekly, 2022, 1922 (1) : 134 - 134
[50] Covid-19-vaccine/rituximabCOVID-19 infection and lack of efficacy caused by drug interactions: case report
Reactions Weekly, 2021, 1879 (1) : 114 - 114

← 1 2 3 4 5 →